Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors

Zhang,Lan; Liu,Peishu; Li,Hua; Xue,Fuying

doi:10.3892/mmr.2013.1371

Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors

Authors:
- Lan Zhang
- Peishu Liu
- Hua Li
- Fuying Xue
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Ji'nan, Shandong 250000, P.R. China, Department of Obstetrics and Gynecology, Tai'an Central Hospital, Tai'an, Shandong 271000, P.R. China
Published online on: March 14, 2013 https://doi.org/10.3892/mmr.2013.1371
Pages: 1705-1709

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the expression of Runt box 3 (RUNX3) and aplasia Ras homolog member I (ARHI) in ovarian tumors, and the effects of histone deacetylase inhibitors (HDACIs) on the expression of these genes and the growth of ovarian cancer cells. The mRNA expression of the RUNX3 and ARHI genes in normal ovaries and ovarian tumors was determined using reverse transcription polymerase chain reaction (RT-PCR). The effects of HDACIs on RUNX3 and ARHI expression in four ovarian cancer cell lines (SKOV3, A2780, COC1 and OC3) were determined using RT-PCR and the MTT assay. The expression of RUNX3 and ARHI in normal ovarian cells was 86 and 100%, respectively. Although the two genes were downregulated in ovarian tumors, the extent of downregulation differed. The expression of RUNX3 and ARHI was correlated with the degree of tumor malignancy (P<0.05). ARHI was expressed in all four ovarian cancer cell lines, whereas RUNX3 was expressed only in the OC3 cell line. Treatment with HDACIs upregulated the expression of ARHI and RUNX3 in the SKOV3 cell line only. In A2780 cells, HDACIs upregulated ARHI expression only in the presence of trichostatin A (TSA) plus cisplatin. HDACIs induced significant apoptosis in ovarian cancer cells, which was inversely correlated with the concentration and duration of treatment (P<0.05). In conclusion, RUNX3 and ARHI were shown to be expressed in normal ovarian cells; however, their expression was downregulated or lost in ovarian tumor cells. The combined detection of ARHI and RUNX3 expression may offer improved prediction and monitoring of ovarian malignancies. HDACIs were revealed to inhibit the growth of ovarian tumor cells and may constitute a novel therapeutic option for ovarian tumors.

View Figures

View References

1	Rosen DG, Wang L, Jain AN, et al: Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res. 10:6559–6566. 2004. View Article : Google Scholar
2	Weber F, Aldred MA, Morrison CD, et al: Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab. 90:1149–1155. 2005. View Article : Google Scholar : PubMed/NCBI
3	Bao JJ, Le XF, Wang RY, et al: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 62:7264–7272. 2002.
4	Yang N, Zhang L, Zhang Y and Kazazian HH Jr: An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 31:4929–4940. 2003. View Article : Google Scholar : PubMed/NCBI
5	Fukamachi H: Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Dev Growth Differ. 48:1–13. 2006. View Article : Google Scholar : PubMed/NCBI
6	Hisatomi H, Nagao K, Wakita K and Kohno N: ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology. 62:136–140. 2002. View Article : Google Scholar : PubMed/NCBI
7	Luo RZ, Peng H, Xu F, et al: Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta. 1519:216–222. 2001. View Article : Google Scholar : PubMed/NCBI
8	Derrane M: Gene imprinting: making an impression on cancer research. J Natl Cancer Inst. 91:16–18. 1999. View Article : Google Scholar : PubMed/NCBI
9	Osaki M, Moriyama M, Adachi K, et al: Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest. 34:605–612. 2004. View Article : Google Scholar : PubMed/NCBI
10	Holzer AK, Katano K, Klomp LW and Howell SB: Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin Cancer Res. 10:6744–6749. 2004. View Article : Google Scholar : PubMed/NCBI
11	Steffensen KD, Waldstrøm M, Grove A, et al: Improved classification of epithelial ovarian cancer: results of 3 danish cohorts. Int J Gynecol Cancer. 21:1592–1600. 2011. View Article : Google Scholar : PubMed/NCBI
12	Takai N, Kawamata N, Gui D, Said JW, Miyakawa I and Koeffler HP: Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Cancer. 101:2760–2770. 2004. View Article : Google Scholar
13	Fujii S, Luo RZ, Yuan J, et al: Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet. 12:1791–1800. 2003. View Article : Google Scholar : PubMed/NCBI
14	Li L, Shi H, Yiannoutsos C, Huang TH and Nephew KP: Epigenetic hypothesis tests for methylation and acetylation in a triple microarray system. J Comput Biol. 12:370–390. 2005. View Article : Google Scholar : PubMed/NCBI
15	Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM and Miller CS: Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol. 11:306–317. 2005. View Article : Google Scholar
16	Woolf E, Xiao C, Fainaru O, et al: Runx3 and Runx 1 are required for CD8 Tcell development during thymopoiesis. Proc Natl Acad Sci USA. 100:7731–7736. 2003. View Article : Google Scholar : PubMed/NCBI
17	Bangsow C, Rubins N, Glusman G, et al: The RUNX3 gene-sequence, structure and regulated expression. Gene. 279:221–232. 2001. View Article : Google Scholar : PubMed/NCBI
18	Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci. 94:360–364. 2003. View Article : Google Scholar : PubMed/NCBI